CompaniesPharmAthene

PharmAthene

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

116

By Phase

PHASE1: 5

By Status

COMPLETED: 3SUSPENDED: 1TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
Today
NCT00744146
NCT00964561
NCT01265745
Hover over trial bars to see details

Recent Trials

NCT01265745Lead Sponsor
Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects
PHASE1Completed
28 participants
Started: Dec 31, 2010 · Completed: Dec 31, 2011
NCT01204866Lead Sponsor
Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use
PHASE1Completed
5 participants
Started: Jul 31, 2010 · Completed: Sep 30, 2010
NCT00964561Lead Sponsor
Ph1 Study of Valortim and Ciprofloxacin in Humans
PHASE1Suspended
26 participants
Started: Aug 31, 2009 · Completed: Jul 31, 2010
NCT00964834Lead Sponsor
Ph1 Study of Valortim and Doxycycline in Humans
PHASE1Terminated
24 participants
Started: Jul 31, 2009 · Completed: Dec 31, 2009
NCT00744146Lead Sponsor
First Time in Human Study of Protexia
PHASE1Completed
33 participants
Started: Sep 30, 2008 · Completed: Nov 30, 2009
Related Companies
Altimmune
merged